Moncrieff, Joanna http://orcid.org/0000-0003-1214-6974
Cooper, Ruth E.
Stockmann, Tom http://orcid.org/0000-0001-9954-1234
Amendola, Simone http://orcid.org/0000-0002-1950-4351
Hengartner, Michael P. http://orcid.org/0000-0002-2956-2969
Horowitz, Mark A. http://orcid.org/0000-0003-1318-2029
Article History
Received: 28 September 2023
Revised: 22 January 2024
Accepted: 24 January 2024
First Online: 19 February 2024
Competing interests
: JM receives royalties for three books about psychiatric drugs, and is a co-applicant on the REDUCE trial, funded by the National Institute of Health Research, evaluating digital support for patients stopping long-term antidepressant treatment. She is co-chairperson of the Critical Psychiatry Network (an informal group of psychiatrists) and a board member of the unfunded organisation, the Council for Evidence-based Psychiatry. Both are unpaid positions. MAH reports being a co-founder of Outro Health which aims to provide digital support for patients in the US to help stop no longer needed antidepressant treatment using gradual, hyperbolic tapering. MAH and JM are both co-applicants on the RELEASE and RELEASE+ trials in Australia evaluating hyperbolic tapering of antidepressants against tapering as usual. MAH is also an Associate of the International Institute for Psychiatric Drug Withdrawal (IIPDW) and a member of the Critical Psychiatry Network. RC is a Board Member of the International Institute for Psychiatric Drug Withdrawal (IIPDW); this is an unpaid position. MPH receives royalties from Palgrave Macmillan for a book about antidepressants. Other authors report no potential conflicts of interest.